Abstract
Objectives To develop a regional model of COVID-19 dynamics, for use in estimating the number of infections, deaths and required acute and intensive care (IC) beds using the South West of England (SW) as an example case.
Design Open-source age-structured variant of a susceptible-exposed-infectious-recovered (SEIR) deterministic compartmental mathematical model. Latin hypercube sampling and maximum likelihood estimation were used to calibrate to cumulative cases and cumulative deaths.
Setting SW at a time considered early in the pandemic, where National Health Service (NHS) authorities required evidence to guide localised planning and support decision-making.
Participants Publicly-available data on COVID-19 patients.
Primary and secondary outcome measures The expected numbers of infected cases, deaths due to COVID-19 infection, patient occupancy of acute and IC beds and the reproduction (“R”) number over time.
Results SW model projections indicate that, as of the 11th May 2020 (when ‘lockdown’ measures were eased), 5,793 (95% credible interval, CrI, 2,003 – 12,051) individuals were still infectious (0.10% of the total SW England population, 95%CrI 0.04 – 0.22%), and a total of 189,048 (95%CrI 141,580 – 277,955) had been infected with the virus (either asymptomatically or symptomatically), but recovered, which is 3.4% (95%CrI 2.5 – 5.0%) of the SW population. The total number of patients in acute and IC beds in the SW on the 11th May 2020 was predicted to be 701 (95%CrI 169 – 1,543) and 110 (95%CrI 8 – 464) respectively. The R value in SW England was predicted to be 2.6 (95%CrI 2.0 – 3.2) prior to any interventions, with social distancing reducing this to 2.3 (95%CrI 1.8 – 2.9) and lockdown/ school closures further reducing the R value to 0.6 (95CrI% 0.5 – 0.7).
Conclusions The developed model has proved a valuable asset for local and regional healthcare services. The model will be used further in the SW as the pandemic evolves, and – as open source software – is portable to healthcare systems in other geographies.
Future work/ applications
Open-source modelling tool available for wider use and re-use.
Customisable to a number of granularities such as at the local, regional and national level.
Supports a more holistic understanding of intervention efficacy through estimating unobservable quantities, e.g. asymptomatic population.
While not presented here, future use of the model could evaluate the effect of various interventions on transmission of COVID-19.
Further developments could consider the impact of bedded capacity in terms of resulting excess deaths.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was funded with support from the Elizabeth Blackwell Institute, Bristol UNCOVER (Bristol COVID Emergency Research) and Medical Research Council UK. LM, KJL, EBP and KMET acknowledge support from the NIHR Health Protection Research Unit in Behavioural Science and Evaluation at the University of Bristol. This work was also supported by Health Data Research UK, which is funded by the UK Medical Research Council, Engineering and Physical Sciences Research Council, Economic and Social Research Council, National Institute for Health Research, Chief Scientist Office of the Scottish Government Health and Social Care Directorates, Health and Social Care Research and Development Division (Welsh Government), Public Health Agency (South Western Ireland), British Heart Foundation and Wellcome.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
-
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
↵† should be considered joint senior author
Data Availability
The model was developed in R and all code and links to source data are freely available (github.com/rdbooton/bricovmod). We used the following publicly-available metrics for model fitting: regional cumulative cases in SW England (tested and confirmed case in hospital), and deaths (daily/cumulative counts) from the Public Health England COVID-19 dashboard, and Office for National Statistics weekly provisional data on COVID-19 related deaths.
